1. Home
  2. BHVN vs AMTM Comparison

BHVN vs AMTM Comparison

Compare BHVN & AMTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • AMTM
  • Stock Information
  • Founded
  • BHVN 2013
  • AMTM 2020
  • Country
  • BHVN United States
  • AMTM United States
  • Employees
  • BHVN N/A
  • AMTM N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • AMTM
  • Sector
  • BHVN Health Care
  • AMTM
  • Exchange
  • BHVN Nasdaq
  • AMTM NYSE
  • Market Cap
  • BHVN 1.9B
  • AMTM 5.6B
  • IPO Year
  • BHVN 2017
  • AMTM N/A
  • Fundamental
  • Price
  • BHVN $14.63
  • AMTM $24.21
  • Analyst Decision
  • BHVN Strong Buy
  • AMTM Buy
  • Analyst Count
  • BHVN 14
  • AMTM 6
  • Target Price
  • BHVN $58.85
  • AMTM $25.50
  • AVG Volume (30 Days)
  • BHVN 2.0M
  • AMTM 2.2M
  • Earning Date
  • BHVN 08-07-2025
  • AMTM 08-05-2025
  • Dividend Yield
  • BHVN N/A
  • AMTM N/A
  • EPS Growth
  • BHVN N/A
  • AMTM N/A
  • EPS
  • BHVN N/A
  • AMTM 0.10
  • Revenue
  • BHVN N/A
  • AMTM $11,261,000,000.00
  • Revenue This Year
  • BHVN $3.00
  • AMTM $70.67
  • Revenue Next Year
  • BHVN $59.97
  • AMTM $2.35
  • P/E Ratio
  • BHVN N/A
  • AMTM $253.45
  • Revenue Growth
  • BHVN N/A
  • AMTM 38.56
  • 52 Week Low
  • BHVN $13.87
  • AMTM $16.01
  • 52 Week High
  • BHVN $55.70
  • AMTM $34.50
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 41.97
  • AMTM N/A
  • Support Level
  • BHVN $14.00
  • AMTM N/A
  • Resistance Level
  • BHVN $15.09
  • AMTM N/A
  • Average True Range (ATR)
  • BHVN 0.73
  • AMTM 0.00
  • MACD
  • BHVN 0.13
  • AMTM 0.00
  • Stochastic Oscillator
  • BHVN 41.44
  • AMTM 0.00

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About AMTM AMENTUM HOLDINGS INC

Amentum Holdings Inc is engaged in engineering and technology solutions. The United States and its allies trust it to address their technical and complex scientific, security, and sustainability challenges.

Share on Social Networks: